Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasisMichele W L Teng, Daniel M Andrews, Nicole McLaughlin, et al.
Cancers|December 24, 2021
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in MelanomaPeter Kar Han Lau, Carleen Cullinane, Susan Jackson, et al.
Clinical & Translational Immunology|July 25, 2020
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cellsJack D Chan, Bianca von Scheidt, Bijun Zeng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2019
Enterotoxins can support CAR T cells against solid tumorsBianca von Scheidt, Minyu Wang, Amanda J Oliver, et al.
Clinical & Translational Immunology|August 25, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapyXiaomeng Zhang, Rachel Xu, Dmitry Zorin, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
Clinical & Translational Immunology|August 22, 2020
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatmentJonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2021
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic CancerAesha I Ali, Minyu Wang, Bianca von Scheidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen SettingClare Y Slaney, Bianca von Scheidt, Alexander J Davenport, et al.
Pageof 3